Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Advocate Thuli Madonsela leads Law Symposium on corruption
2014-06-05

 

Advocate Thuli Madonsela speaking at the Law Symposium on corruption.

The Faculty of Law, Centre of Business Law held a symposium on corruption in the public sector. The symposium took place on 5 June 2014 in the CR Swart Auditorium on the Bloemfontein Campus.

In her keynote address, Public Protector Adv Thuli Madonsela highlighted the government’s efforts to curb the high rate of corruption prevalent in the South African public sector. She also pointed out the effect it has had on service delivery, especially in municipalities and key government departments.

This highly-anticipated event drew a large group consisting of members of the public, the judiciary, government, non-governmental organisations, as well as the business and academic sector.

Responding to questions from the floor, Adv Madonsela spoke of corruption as an on-going problem that should be tackled in a collective effort by government officials and the public alike. “Whistleblowers are our main hope in fighting corruption … The Protected Disclosures Act protects them … it is also management’s responsibility to protect whistleblowers,” she said.

The symposium featured several well-respected names, including:
• Prof Jonathan Jansen, Vice-Chancellor and Rector;
• Honourable Justice I van der Merwe, Judge of the Free State High Court and Chairman of the Council of the UFS;
• Honourable Justice FDJ Brand, Judge of the Supreme Court of Appeal; and
• Prof JJ Henning, Acting Dean of the Faculty of Law.

Other high-ranking legal professionals from the office of the Director of Public Prosecutions, PriceWaterhouseCoopers, the Free State High Court and the Institute of Security Studies attended the event.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept